Spyre Therapeutics has appointed Kate Tansey Chevlen as Chief Commercial Officer.

Approximately 70% of metastatic triple-negative breast cancer patients are ineligible for immunotherapy, creating an unmet ...

If we don’t have compassion, we really do need to question what that says about us as individuals and organisations ...

Turn interaction into intelligence! Don’t miss this chance to lead the industry with our free pharma-exclusive webinar!

Union Chimique Belge (UCB) has announced the release of new positive data regarding Bimzelx (bimekizumab) in moderate to ...

Over 50 million people across the US live with acne, a condition with no cure that often requires chronic treatment ...

While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with ...

ASH 2025 showed up with a clenched fist and never loosened it. Under the rallying call of ‘Fight 4 Hematology’, the meeting ...

Gastric cancer is the fifth highest cause of cancer deaths worldwide, with almost a million people diagnosed annually ...

McNamara’s Fallacy is the error of making decisions based solely on easily quantifiable data, while ignoring ...

With GENEROUS, GUARD, and GLOBE all released since December, 185 pages of policy will materially impact U.S. drug pricing — ...

Johnson & Johnson has announced that its Darzalex Faspro-based regimen (daratumumab and hyaluronidase, in combination with ...